| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar … LN Yatham, SH Kennedy, SV Parikh, A Schaffer, DJ Bond, BN Frey, ... Bipolar disorders 20 (2), 97-170, 2018 | 1515 | 2018 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of … LN Yatham, SH Kennedy, SV Parikh, A Schaffer, S Beaulieu, M Alda, ... Bipolar disorders 15 (1), 1-44, 2013 | 1067 | 2013 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of … LN Yatham, SH Kennedy, A Schaffer, SV Parikh, S Beaulieu, ... Bipolar disorders 11 (3), 225-255, 2009 | 783 | 2009 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies LN Yatham, SH Kennedy, C O'Donovan, S Parikh, G MacQueen, ... Bipolar disorders 7, 5-69, 2005 | 516 | 2005 |
| Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives T Baptista, N Kin, S Beaulieu, EA De Baptista Pharmacopsychiatry 35 (06), 205-219, 2002 | 400 | 2002 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007 LN Yatham, SH Kennedy, C O'Donovan, SV Parikh, G MacQueen, ... Bipolar disorders 8 (6), 721-739, 2006 | 333 | 2006 |
| The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments F Ng, OK Mammen, I Wilting, GS Sachs, IN Ferrier, F Cassidy, S Beaulieu, ... Bipolar disorders 11 (6), 559-595, 2009 | 225 | 2009 |
| Differential effects of adrenergic and corticosteroid hormonal systems on human short-and long-term declarative memory for emotionally arousing material. FS Maheu, R Joober, S Beaulieu, SJ Lupien Behavioral neuroscience 118 (2), 420, 2004 | 209 | 2004 |
| Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback … S Beaulieu, T Di Paolo, N Barden Neuroendocrinology 44 (2), 247-254, 1986 | 208 | 1986 |
| Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial T Baptista, N Rangel, V Fernández, E Carrizo, Y El Fakih, E Uzcátegui, ... Schizophrenia research 93 (1-3), 99-108, 2007 | 199 | 2007 |
| Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial T Baptista, J Martínez, A Lacruz, N Rangel, S Beaulieu, A Serrano, ... The Canadian Journal of Psychiatry 51 (3), 192-196, 2006 | 197 | 2006 |
| Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic … S Beaulieu, T DiPaolo, J Côté, N Barden Neuroendocrinology 45 (1), 37-46, 1987 | 192 | 1987 |
| A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study SV Parikh, A Zaretsky, S Beaulieu, LN Yatham, LT Young, I Patelis-Siotis, ... The Journal of clinical psychiatry 73 (6), 16669, 2012 | 182 | 2012 |
| The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit … DJ Bond, G Hadjipavlou, RW Lam, RS McIntyre, S Beaulieu, A Schaffer, ... Ann Clin Psychiatry 24 (1), 23-37, 2012 | 163 | 2012 |
| Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures MC Pepin, S Beaulieu, N Barden Molecular Brain Research 6 (1), 77-83, 1989 | 163 | 1989 |
| Pharmacological management of atypical antipsychotic-induced weight gain T Baptista, Y ElFakih, E Uzcátegui, I Sandia, E Tálamo, EA de Baptista, ... CNS drugs 22, 477-495, 2008 | 157 | 2008 |
| Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics T Baptista, J Zarate, R Joober, C Colasante, S Beaulieu, X Paez, ... Current Drug Targets 5 (3), 279-299, 2004 | 153 | 2004 |
| The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders RS McIntyre, M Alsuwaidan, BI Goldstein, VH Taylor, A Schaffer, ... Ann Clin Psychiatry 24 (1), 69-81, 2012 | 145 | 2012 |
| Rapid cycling bipolar disorder–diagnostic concepts M Bauer, S Beaulieu, DL Dunner, B Lafer, R Kupka Bipolar disorders 10 (1p2), 153-162, 2008 | 129 | 2008 |
| Comparative effects of the antipsychotics sulpiride or risperidone in rats: I: Bodyweight, food intake, body composition, hormones and glucose tolerance T Baptista, EA de Baptista, NMKNY Kin, S Beaulieu, D Walker, R Joober, ... Brain Research 957 (1), 144-151, 2002 | 129 | 2002 |
Verinder SharmaProfessor of Psychiatry, Western University, Canada在 uwo.ca 的电子邮件经过验证
